Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd news stories on ALFA NewsRead the news →- Share price
- ₹1,029.95
- Market cap
- ₹20,245 Cr
- Revenue (annual)
- ₹7,345 Cr
- Net profit (annual)
- ₹674.8 Cr
- P/E (TTM)
- 24.0×Sector 43.8×
- Promoter holding
- 69.87%+0.00% QoQ
- FII holding
- 4.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Regulatory Approval 3Other Announcement 2Merger & Restructuring 2Results Update 1Partnership 1Financial Results 1Earnings Call 1Board Meeting Date 1
Time
0 announcements with these filters
Nothing in this window
Try another type or a longer time range.